'Amyloid is not a tombstone' - A summation. The primary role for cerebrovascular and CSF dynamics as factors in Alzheimer's disease (AD): DMSO, fluorocarbon oxygen carriers, thyroid hormonal, and other suggested therapeutic measures

Annals of the New York Academy of Sciences

Volumn 826, Issue , 1997, Pages 348-374

  Regelson, William ^a   Harkins, S W ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PROTEIN; CHOLINERGIC RECEPTOR STIMULATING AGENT; CHOLINESTERASE INHIBITOR; CORTICOTROPIN RELEASING FACTOR; DIMETHYL SULFOXIDE; FLUOROCARBON; MELATONIN; PERFLUOROOCTYL BROMIDE; PRASTERONE; PREALBUMIN; PREGNENOLONE; PROTEOGLYCAN; RETINOL; TETRAHYDROBIOPTERIN; THYROID HORMONE;

AGING; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; BASEMENT MEMBRANE; BRAIN BLOOD FLOW; BRAIN BLOOD VESSEL; BRAIN DEVELOPMENT; CEREBROSPINAL FLUID; CEREBROVASCULAR DISEASE; CHOROID PLEXUS; CONFERENCE PAPER; DOWN SYNDROME; FAT EMBOLISM; HUMAN; MAST CELL; NONHUMAN; THYROID FUNCTION;

ANIMALIA;

EID: 0030681381     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1997.tb48485.x     Document Type: Conference Paper

References (214)

1. RELKIN, N. R., M. A. EDGAR, G. K. GOURAS, S. E. GARDY & H. S. GOLDSMITH. 1996. Decreased senile plaque density in Alzheimer neocortex adjacent to an omental transposition, Neurol. Res. 18: 291-294.
2. DE LA TORRE, J. C. 1996. Comment on omental transposition: decreased senile plaque density in Alzheimer neocortex adjacent to omental transposition. Neurol. Res. 18: 295-296.
3. GOLDSMITH, H. S. 1996. Omental transposition for Alzheimer's disease. Neurol. Res. 18: 103-108.
4. GOLDSMITH, H. S. 1994. Brain and spinal cord revascularization by omental transposition. Neurol. Res. 16: 159-162.
5. GOLDSMITH, H. S. 1996. First International Congress of Omentum in CNS. Surg. Neurol. 45: 87-90.
6. GOLDSMITH, H. S. Ed. 1988. The Omentum. Springer-Verlag. New York.
7. 6: 229-240.
8. SCHEIBEL, A. B., T. DUONG & U. TOMIYASU. 1996. Microvascular changes in Alzheimer's disease. In The Biological Substrates of Alzheimer's Disease. A. B. Scheibel, A. F. Wechsler & M. A. B. Brazier, Eds:. 177-192. Academic Press, New York.
9. MIYAKAWA, T. 1997. Electron microscopy of amyloid fibrils and microvessels. Ann. N. Y. Acad. Sci. This volume.
10. BUÉE, L., P. R. HOF & A. DELACOURTE. 1997. Brain microvascular changes in Alzheimer's disease and other dementias. Ann. N. Y. Acad. Sci. This volume.
11. DE LA TORRE, J. C. 1997. Hemodynamic consequences of deformed microvessels in the brain in Alzheimer's disease. Ann. N. Y. Acad. Sci. This volume.
12. PAPPAS, B. A., C. M. DAVIDSON, S. A. L. BENNET et al. 1997. Chronic ischemia: Memory impairment and neural pathology in the rat. Ann. N. Y. Acad. Sci. This volume.
13. OLICHNEY, J., R. ELLIS, R. KATZMAN et al. 1997. Types of cerebrovascular lesions associated with severe cerebral amyloid angiopathy in Alzheimer's disease. Ann N. Y. Acad. Sci. This volume.
14. COHEN, D. L., P. HEDERA et al. 1997. Amyloid-β protein angiopathies masquerading as Alzheimer's disease? Ann. N. Y. Acad. Sci. This volume.
15. MORONEY, J. T., E. BAGIELLA, D. W. DESMOND et al. 1997. Misclassification of dementia subtype using the Hachinski Ischemic score. Ann. N. Y. Acad. Sci. This volume.
16. SIDENNICKI-LANTZ, A., S. ELMSTAHL & B. LILJA. 1996. Orthostatic hypotension in Alzheimer's disease correlates with decreased cerebral blood flow. Displayed at this symposium.
17. HOYER, S., R. NITSCH & K. OESTERREICH. 1991. Predominant abnormality in cerebral glucose utilization in late-onset dementia of the Alzheimer type. J. Neural. Transm. Park. Dis. Dement. Sect. 3: 1-14.
18. HARKINS, S. W., J. R. TAYLOR, V. MATTAY & W. REGELSON. 1996. Tacrine (THA) enhances cerebral blood flow and mental status in some dementia Alzheimer type patients. Displayed at this symposium.
19. JAGUST, W. et al. 1997. Clinical studies of cerebral blood flow in Alzheimer's disease. Ann. N. Y. Acad. Sci. This volume.
20. BROWN, W. R., D. M. MOODY, M. TYTELL et al. 1997. Microembolic brain injuries from cardiac surgery: Are they seeds of future Alzheimer's disease? Ann. N. Y. Acad. Sci. This volume.
21. ROACH, G. W., M. KANCHUNGER, C. M. MANGANO et al. 1996. Adverse cerebral out-comes after coronary bypass surgery. N. Eng. J. Med. 335: 1857-1863.
22. KALARIA, R. N. 1997. Microvascular degeneration is related to amyloid-β protein deposition in Alzheimer's disease. Ann. N. Y. Acad. Sci. This volume.
23. ZAROW, C., E. BARROW, H. CHANG-CHUI & L. S. PERLMUTTER. 1997. Vascular basement membrane pathology and Alzheimer's disease. Ann. N. Y. Acad. Sci. This volume.
24. KISILEVSKY, R. 1997. Can deposition of amyloid be prevented in Alzheimer's disease? Ann. N. Y. Acad. Sci. This volume.
25. THOMAS, T., C. MCLENDON et al. 1997. β-Amyloid-induced cerebrovascular endothelial dysfunction. Ann. N. Y. Acad. Sci. This volume.
26. COHEN, D. L., P. HEDERA et al. 1997. Amyloid-β protein angiopathies masquerading as Alzheimer's disease? Ann. N. Y. Acad. Sci. This volume.
27. PANTONI, L. & J. H. GARCIA. 1997. Cognitive impairment and cellular/vascular changes in cerebral white matter. Ann. N. Y. Acad. Sci. This volume.
28. LINDAHL, B., L. ERIKSSON, D. SPILLMANN et al. 1996. Keratin Sulfate in Alzheimer's Disease. J. Biol. Chem. 271: 16991-16994.
29. SEKIGUCHI, R. T., S. POTTER-PERIGO, K. BRAUN et al. 1994. Characterization of proteoglycans by murine embryonal carcinoma cells (P 19) reveal increased expression of Perlecan (heparan sulfate) during neuronal differentiation. J. Neurosci. Res. 38: 670-686.
30. SMALL, D. H., V. NURCOMBE, G. REED et al. 1994. A heparin-binding domain in the amyloid protein precursor of Alzheimer's disease is involved in the regulation of neurite outgrowth. J. Neurosci. 14: 2117-2127.
31. LEVEUGLE, B., W. DING, L. BUÉE & H. M. FILLIT. 1995. Interleukin-I and nerve growth factor induce hypersecretion and hypersulfation of neuroblastoma proteoglycans which bind B amyloid. J. Neuroimmunol. 60: 151-160.
32. CLARRIS, H. J., V. NURCOMBE, D. H. SMALL et al. 1994. Secretion of nerve-growth factor from septum stimulates neurite outgrowth and release of amyloid protein precursor of Alzheimer's disease from hippocampal explants. J. Neurosci. Res. 38: 248-258.
33. SU, J. H., B. J. CUMMINGS & C. N. COTMAN. 1992. Localization of heparan sulfate glycosaminoglycan and proteoglycan core protein in aged brain and Alzheimer's disease. Neuroscience 51: 810-813.
34. GUPTA-BANSAL, R., R. C. FREDRICKSON & K. R. BRUNDEN. 1995. Proteoglycan-mediated inhibition of beta-proteolysis. A potential cause of senile plaque accumulation. J. Biol. Chem. 270: 1856-1871.
35. INOUE, S., P. G. HOLTIN, W. A. SZAREK & R. KISILEVSKY. 1996. Effect of poly(vinylsulfonate) on murine SAA amyloid: A high resolution ultrastructure study. Lab. Invest. 74: 1081-1090.
36. REGELSON, W. 1968. The growth regulating activity of polyanions. Advances in Cancer Research 11: 223-304.
37. CHIBA, N. 1991. Immunohistochemical study on the extracellular components in various renal diseases. Nippon-Jinzo-Gakkai-Shi 33: 925-938.
38. VAN-DEN-BORN, J., L. P. VAN-DEN-HEUVEL, M. A. BAKKER et al. 199?. Distribution of GBM heparin sulfate proteoglycan core protein and side chains in human glomerular diseases. Kidney Int. 43: 454-463.
39. HORNER, A. A. 1991. Heterogeneous distribution of anti-thrombin binding sites in rat brain heparan sulphate proteoglycans. Biochem. J. 280: 393-397.
40. MARATHIAS, K., M. LAMBRACHT-HALL, J. SAVALA & T. C. THEOHARIDES. 1991. Endogenous regulation of rat brain mast cell serotonin release. Int. Arch. Allergy Appl. Immunol. 95: 332-340.
41. NELSON, R. B., R. SIMAN, M. A. IQBAL & H. POTTER. 1993. Identification of a chymotrypsin-like mast cell protease in rat brain capable of generating the N-terminus of the Alzheimer beta-protein. J. Neurochem. 61: 567-577.
42. THEOHARIDES, T. C., C. SPANOS, X. PANG et al. 1995. Stress induced intracranial mast cell degranulation: A corticotrophin-releasing hormone-mediated effect. Endocrinology 136: 5745-5756.
43. SHALIT, M., T. BRENNER, E. SHOHAMI & F. LEVI-SCHAEFFER. 1993. Interaction between mast cells and glial cells: An in vitro study. J Neuroimmunol 43: 195-199.
44. FERNANDEZ-NOVOA, L. et al. 1997. Global deterioration scale-related brain hemodynamics and histamine levels in Alzheimer's disease and vascular dementia. Ann. N. Y. Acad. Sci. This volume.
45. ALOE, C., S. D. SKAPER, A. LEON & R. LEVI-MONTALCINI. 1994. Nerve growth factor and autoimmune diseases. Autoimmunity 19: 141-150.
46. THEOHARIDES, T. C., V. DIMITIADOU, R. LETOURNEAVI et al. 1993. Synergistic action of estradiol and myelin basic protein on mast cell secretion and brain myelin changes resembling early stages of demyelination. Neuroscience 57: 861-871.
47. NECHUSHTAN, H., H. SOREQ, V. KUPERSTEIN et al. 1996. Murine and human mast cells express acetylcholinesterase. FEBS Lett. 379: 1-6.
48. PURCELL, W. & C. K. ATTERWILL. 1995. Mast cells in neuroimmune function: Neurotoxicological and neuropharmacological perspectives. Neurochem. Res. 20: 521-532.
49. REGELSON, W. & M. Y. KALIMI. 1996. DHEA (Dehydroepiandrosterone): A pleiotropic steroid. How can one steroid do so much? In Advances in Anti-Aging Medicine. Ron M. Klatz, Ed.: 298-317. Mary Ann Liebert. New York.
50. FARRER, L. S., J. ROBBINS, B. S. GLUMBERG & J. E. RALL. 1962. Thyroxine-serum protein complexes in various animals. Endocrinology 70: 686-695.
51. LARSSON, M., T. PETERSON & A. CARLSTROM. 1985. Thyroid hormone binding in serum of 15 vertebrate species: isolation of thyroxine-binding globulin and prealbumin analogs. Gen. Comp. Endocrinol. 58: 360-372.
52. BLONDEAU, J-P., J. OSTY & J. FRANCON. 1988. Characterization of the thyroid hormone transport system of isolated hepatocytes. J. Biol. Chem. 263: 2685-2702.
53. GARCIN, H., P. HIGUERET & K. AMOIKON. 1984. Effects of a large dose of retinol on retinoic acid on thyroid hormones in the rat. Ann. Nutr. Metab. 28: 92-100.
54. GLASS, A. R., R. A. YOUNG & J. ANDERSON. 1986. Decreased serum 3,5,3 triodothyronine (T3) and abnormal serum binding of T3 in caloric deficient rats. Adaptation after chronic underfeeding. Endocrinology 118: 2464-2469.
55. WADE, S., F. BLEIBERG-DANIEL & B. LEMOULLAC. 1988. Rat transthyretin: Effect of acute short term food deprivation and refeeding on serum cerebrospinal fluid concentration and on hepatic RNA levels. J. Nutr. 118: 119-205.
56. FELDING, P. & G. FAX. 1985. Rate of synthesis of prealbumin and retinol binding protein during acute inflammation in the rat. Acta Physiol. Scandinav. 123: 477-483.
57. DICKSON, P. W., A. R. ALDRED, P. D. MARLEY et al. 1986. Rat choroid plexus specializes in the synthesis and secretion of transthyretin (prealbumin). Regulation of transthyretin synthesis in choroid plexus is independent from the liver. J. Biol. Chem. 261: 3475-3478.
58. BROUWER, A. & K. J. VAN DEN BERG. 1986. Binding of a metabolite of 3,4,3′,4′ tetrachlorobiphenyl to transthyretin reduces serum vitamin A transport by inhibiting the formation of the protein complex carrying both retinol and thyroxin. Toxicol. Appl. Pharmacol. 85: 301-312.
59. MCKINNEY, J. D., K. CHRE, S. J. OATLEY, & C. C. F. BLAKE. 1985. Molecular interactions of toxic chlorinated dibenzo-p-dioxins and dibenzofurans with thyroxine binding prealbumin. J. Med. Chem. 28: 375-381.
60. WADA, L. & J. C. KING. 1986. Effect of low zinc intakes on basal metabolic rate, thyroid hormones and protein utilization in adult men. J. Nutr. 116: 1045-1053.
61. FOSTER, R. U. 1987. Disease family trees. The possible roles of iodine in goiter, cretinism, multiple sclerosis, amyotrophic lateral sclerosis, Alzheimer's disease and Parkinson's disease and cancers of the thyroid, nervous system and skin. Med. Hypoth. 24: 249-264.
62. PREMANCHANDRA, B. N., J. WORTMAN, B. C. NISULA & I. K. WILLIAMS. 1986. Modulation of thyroid parameters by exogenous thyroxine in familial dysalbuminemic hyperthyroxemia. Metabolism 35: 283-286.
63. HAYASHI, M. & A. J. PATEL. 1982. An interaction between thyroid hormone and nerve growth factor in the regulation of choline acetyltransferase activity in neuronal cultures derived from the septal band region of the embryonic rat brain. Dev. Brain Res. 36: 107-120.
64. HEFTI, F., J. HARTIKKA & M. B. BOLGER. 1986. Effect of thyroid hormone analogs on the activity of choline acetyltransferase in cultures of dissociated septal cells. Brain Res. 375: 413-416.
65. SEIGER, A. & A. C. GRANHOLM. 1981. Thyroxin dependency of the developing locus coeruleus. Cell Tiss. Res. 220: 1-15.
66. OWASOYO, J. G., G. N. BUNIKE & C. A. IRAMIN. 1981. The influence of thyroid gland and thyroxine on the acetylcholinesterase activity of rat brain and adenohypothesis. Endokrinologie 77: 242-250.
67. MORLEY, J. E., R. M. RUSSELL, A. REED et al. 1981. The interrelationship of thyroid hormones with vitamin A. Am. J. Clin Nutr. 34: 1489-1495.
68. BARDEN, J. S. 1977. Vitamin A and carotene values of institutionally retarded subjects with and without Down's syndrome. Ment. Defic. Res. 21: 63-74.
69. MAURY, C. P. & A. M. TEPPO. 1987. Immunodetection of protein composition of cerebral amyloid extracts in Alzheimer's disease. Enrichment of retinol binding protein. J. Neurol. Sci. 80: 221-228.
70. AULD, R. M., A. M. POMMER, J. C. HOUCK & F. G. BURKE. 1959. Vitamin A absorption in mongoloid children. A preliminary report. Am. J. Ment. Defic. 63: 1010-1013.
71. PALMER S. 1978. Influence of vitamin A nutrition on the immune response: Findings in children with Down's syndrome. Int. J. Vit. Nutr. Reg. 48: 188-216.
72. FABRIS, N., E. MOCCHEGIANI, M. MOZZIOLI & M. PROVINCALI. 1988. Neuroendocrine thymus interactions: Perspectives for intervention in aging. Ann. N. Y. Acad. Sci. 521: 72-87.
73. WEINBERG, T. 1984. Alzheimer's disease: A study of epidemiological aspects. Ann. Neurol. 15: 335-341.
74. ELLIS, W. G., J. R. MCCULLOCH & C. L. CORLEY. 1974. Presenile dementia in Down's syndrome: Ultrastructure identity with Alzheimer's disease. Neurology 24: 101-106.
75. SHARAV, T., R. M. COLLINS & P. J. BAAB. 1988. Growth studies in infants and children with Down's syndrome and elevated levels of thyrotropin. Am. J. Dis. Child. 142: 1302-1306.
76. BASS, N. H., E. W. PELLTON & E. YOUNG. 1977. Defective maturation of cerebral cortex: An inevitable consequence of dysthyroid state during early postnatal life. In Thyroid Hormones and Brain Development. G. D. Grave, Ed.: 199-214. Raven Press, New York.
77. PUESCHEL, S. M. & J. C. PEZZULLO. 1985. Thyroid dysfunction in Down's syndrome. Am. J. Dis. Child. 139: 636-639.
78. FORT, P., F. J. LIFSHITZ, R. BELUSARTO et al. 1984. Abnormalities of thyroid function in infants with Down's syndrome. J. Pediatr. 104: 545-549.
79. CUTLER, R. G., R. BENZERA-OBEITER & S. J. BRINK. 1986. Thyroid function in young children with Down's syndrome. Am. J. Dis. Child. 140: 479-483.
80. LEJEUNE, J., M. PEETERS, M. C. DEBLOIS et al. 1988. Fonction thyroidienne et trisomie 21 excess de TSH et deficit en T3. Ann. Genet. 31: 137-143.
81. LEONARD, J. L., M. M. KAPLAN, T. J. VISSER et al. 1981. Cerebral cortex responds rapidly to thyroid hormones. Science 214: 571-573.
82. DAVID S. & E. J. H. NATHANIEL. 1981. Development of brain capillaries in euthyroid and hypothyroid rats. Exp. Neurol. 73: 243-250.
83. GRESIK, E. W., H. VAN DER NOEN & T. BARKA. 1981. Hypertrophic and hyperplastic effects of thyroxine on submandibular glands of the mouse. Anat. Rec. 200: 243-248.
84. MOSIER, J. H. D. 1981. Thyroid hormone. In Endocrine Control of Growth. W. H. Daughaday, Ed.: 25-32. Elsevier. New York.
85. 2 consumption as a specific index of thyroid status. Standardization of method. Endocrinology 93: 61-72.
86. REGELSON, W. 1983. The evidence for pituitary and thyroid control of aging: Is age reversal a myth or reality? The search for a "death hormone." In Intervention in the Aging Process. W. Regelson & M. Sinex, Eds. Part B: 3-52. Alan R. Liss. New York.
87. EVERITT, A. V. 1976. Cardiovascular aging and the pituitary. In Hypothalamus, Pituitary and Aging. A. V. Everitt & J. A. Burgess, Eds.: 281-290. Charles C Thomas. Springfield, Illinois.
88. EVERITT, A. V. & L. DELBRIDGE. 1976. The role of the pituitary and thyroid in the aging of collagen in rat tail tendon. In Hypothalamus, Pituitary and Aging. A. V. Everitt and J. A. Burgess, Eds.: 193-200. Charles C Thomas. Springfield, Illinois.
89. LINDSTEDT, G., P-A. LUNDBERG & B. SJOGREN. 1982. Thyroid hormone resistance in a 35 year old man with recurrent goitre. Scand. J. Clin. Lab. Invest. 42: 585-593.
90. REGELSON, W. & C. COLEMAN. 1996. Thyroid hormone. In The Superhormone Promise: 189-202. Simon and Schuster. New York.
91. COLE, G. M., P. E. SEGALL & P. S. TIMARIS. 1982. Hormones during aging. In Hormones and Development and Aging. A. Vernadakis & P. S. Timaris, Eds.: 477-490. Spectrum.
92. NARANG, G. D. & C. W. TURNER. 1966. Effect of advancing age on thyroid hormone excretion rates of female rats. Proc. Soc. Exp. Biol. Med. 121: 203-206.
93. HAUNG, H. H., R. W. STEGER & J. MEITES. 1980. Capacity of old versus young male rats to release thyrotropin (TSH), thyroxine (T4) and triiodothyronine (T3) in response to different stimuli. Exp. Aging Res. 6: 3-14.
94. BAKER, S. P., G. W. GAFFNEY, N. W. SHOCK & M. LANDOWNE. 1959. Physiological responses of five middle-aged and elderly men to repeated administration of thyroid stimulating hormone. J. Gerontol.: 37-45.
95. SZABOLICS, I., G. SZILAGYI, M. GOTH et al. 1981. Plasma triiodothyronine response to thyrotropin releasing hormone, thyrotropin and propranolol in old age. Exp. Gerontol. 16: 307-315.
96. CHEN, H. J., WALFISH, P. G. 1979. Effects of age on the pituitary thyroid system of female and male rats. In Endocrine Aspects of Aging. S. G. Korenman, Ed. Endocrine Society and VA Conference, October 18-20.
97. SAWIN, C. T., D. CHOPRA, F. AZIZI et al. 1979. The aging thyroid. JAMA 242: 247-252.
98. SEGAL, J., B. R. TROEN & S. H. INGMAR. 1982. Influence of age and sex on the concentration of thyroid hormone in serum of the rat. J. Endocrinol. 93: 177-181.
99. FRANKLYN, J. A., D. B. RAMSDEN & M. C. SHEPPARD. 1925. The influence of age and sex on tests of thyroid function. Ann. Clin. Biochem. 22: 502-505.
100. ELOVERRA, I., A. ICEN, J. PALO & T. ERKINJUNTTI. 1985. Cerebrospinal fluid in Alzheimer's disease: Studies of blood-brain barrier function and intrathecal protein synthesis. J. Neurol. Sci. 70: 73-80.
101. ELOVERRA, I., C. P. J. MAURY & J. PAOLO. 1986. Serum amyloid: A protein albumin and prealbumin in Alzheimer's disease and in demented patients with Down's syndrome. Acta Neurol. Scandinav. 74: 245-250.
102. ELOVERRA, I., J. PALO, T. ERKINJUNTTI, R. SULKAVA. 1987. Serum and Cerebrospinal fluid protein and blood-brain barrier in Alzheimer's disease and multi-infarct dementia. Eur. J. Neurol. 26: 229-234.
103. SHIRAHAMA, T., M. SKINNER, P. WESTERMARK et al. 1982. Senile cerebral amyloid prealbumin as a common constituent in the neuritic plaque in the neurofibrillary tangle and in the microangiopathic lesion. Am J. Pathol. 107: 41-50.
104. PRAS, M., F. PRELLI, E. C. FRANKLIN & B. FRANGIONE. 1983. Tertiary structure of an amyloid prealbumin variant in familial neuropathy of Jewish origin. Proc. Natl. Acad. Sci. USA 80: 539-542.
105. REFETOFF, S., F. E. DWULET & M. D. BENSON. 1986. Reduced affinity for thyroxine in two of three structural thyroxine binding prealbumin variants associated with familial amyloidotic polyneuropathy. J. Clin. Endocrinol. Metab. 63: 1432-1437.
106. KOSHIBA, K. 1987. Ultrastructure of the choroid plexus epithelium of pigeons treated with drugs I. Effect of thyroxin, 2,4 dinitrophenol and cyclohexamide. Am. J. Anat. 178: 126-132.
107. DICKSON, P. W., A. R. ALDRED, J. G. T. MENTING et al. Thyroxin transport in choroid plexus. J. Biol. Chem. 262: 13907-13915.
108. ERICKSSON, ? & P. WESTERMARK. 1986. Intracellular neurofibrillatory tangle-like aggregations. A constantly present amyloid alteration in the aging choroid plexus. Am. J. Pathol. 125: 125-129.
109. JACOBSEN, M., G. K. JACOBSEN, P. P. GLAUSEN et al. 1982. Intracellular plasma proteins in human fetal choroid plexus during development. II. The distribution of prealbumin, albumin, alpha-fetoprotein transferrin, IgG, IgM and alpha antitrypsin. Dev. Brain Res. 3: 251-262.
110. JACOBSSON, B., V. P. COLLINS, L. GRIMELIUS et al. 1989. Transthyretin immunoreactivity in human porcine liver, choroid plexus and pancreatic islets. J. Histochem. Cytochem. 37: 31-37.
111. HERBERT, J., J. N. WILCOX, C. P. KIM-THU et al. 1986. Transthyretin: A choroid plexus-specific transport protein in human brain. Neurology 36: 900-911.
112. STAUDER, A. J., P. W. DICKSON & A. R. ALDRED. 1986. Synthesis of transthyretin (prealbumin) in RNA in thyroid plexus epithelial cells localized by in situ hybridization in rat brain. J. Histochem. Cytochem. 34: 949-952.
113. KIRKERY, O. J., I. R. RISE & C. RISCOE. 1995. Rhythmical fluctuations of the intracranial microcirculation studied in pigs. Int. J. Microcirc. Clin. Exp. 15: 316-324.
114. MCKINNEY, J. S., K. A. WILLOUGHBY, S. LIANG & E. F. ELLIS. 1996. Stretch-induced injury of cultured neuronal and endothelial cells. Effect of polyethylene glycol-conjugated superoxide dismutase. Stroke 27: 934-940.
115. ELLIS, E. F., J. S. MCKINNEY & K. A. WILLOUGHBY et al. 1995. A new model for rapid stretch-induced injury of cells in culture: Characterization of the model using astrocytes. J. Neurotrauma 12: 325-339.
116. 2+ blockade of NMDA current in mechanically injured neurons. Science In press.
117. DE LA TORRE, J. C. 1997. Hemodynamic consequences of deformed microvessels in the brain in Alzheimer's disease. Ann. N. Y. Acad. Sci. This volume.
118. BROWN, W. R. 1997. Microembolic brain injuries from cardiac surgery: Are they seeds of future Alzheimer's disease? Ann. N. Y. Acad. Sci. This volume.
119. FOLDI, M., B. CSILLIK & O. T. ZOLTAN. 1968. Lymphatic drainage of the brain. Experentia 24: 1283-1287.
120. CAMPBELL, J. K., J. M. CLARK, D. N. WHITE & C. O. JENKINS. 1970. Pulsatile echoencephalography. Acta Neurol. Scandina. Suppl. 47: 21-58.
121. LAM, A. M., B. F. MATTA, T. S. MAYBERG & S. STREBEL. 1995. Change in cerebral blood flow velocity with onset of EEG silence during inhalation anesthesia in humans. Evidence of flow-metabolism coupling. J. Cereb. Blood Flow Metab. 15: 714-717.
122. BOULAY, G., J. O'CONNELL, J. CURRIE et al. 1972. Further investigations on pulsatile movement in the cerebrospinal fluid pathways. Acta Radiologica 13: 496-523.
123. GREITZ, D., R. WIRESTAM, A. FRANCK et al. 1992. Pulsatile brain movement and associated hydrodynamics studied by magnetic resonance phase imaging. Neuroradiology 34: 370-380.
124. SCHROTH, G. & U. KLOSE. 1992. Cerebrospinal fluid flow. III. Pathological CSF pulsations. Neuroradiology 35: 16-24.
125. EMERSON, J. F., P. C. CHEN & W. R. SHANKLE. 1994. Cortical CSF volume fluctuations by MRI in brain aging, dementia and hydrocephalus. NeuroReport 5: 1699-1704.
126. SCHROTH, G. & U. KLOSE. 1992. Cerebrospinal fluid flow. I and II. Physiology of cardiac related pulsation. Neuroradiology 35: 1-9.
127. LEVY, L. M. & G. D. CHIRO. 1990. MRI phase imaging and cerebrospinal flow in the head and spine. Neuroradiology 32: 399-406.
128. RICHARDSON, J. S. 1997. Cerebral microischemia as a potential precipitant of the neurodegenerative cascade of Alzheimer's disease. Ann. N. Y. Acad. Sci. This volume.
129. JOHN, E. R., L. S. PRINCHER, J. FRIEDMAN & P. EASSTON. 1988. Neurometrics: Computer-assisted differential diagnosis of brain dysfunctions. Science 239: 162-169.
130. LEUCHTER, A. F., J. E. SPAR, D. O. WALTER & H. WEINER. 1987. Electroencephalographic spectra and coherence in the diagnosis of Alzheimer's type and multi-infarct dementia. Arch. Gen. Psychiatry 44: 993-998.
131. LEUCHTER, A. F., S. L. READ, J. SHAPIRA et al. 1991. Stable bi-modal responses to cholomimetic drugs in Alzheimer's disease. Neuropsychopharmacology 4: 165-173.
132. LEUCHTER, A. F., T. F. NEWTON, I. A. COOK et al. 1992. Changes in brain functional connectivity in Alzheimer-type and multi-infarct dementia. Brain 115: 1543-1561.
133. DUNKIN, J. J., S. OSATO, A. F. LEUCHTER. 1995. Relationships between EEG coherence and neuropsychological tests in dementia. Clin. Electroencephalogr. 2: 47-59.
134. LEUCHTER, A. F., I. A. COOK & R. B. LUFKIN. 1994. Cordance: A new method for assessment of cerebral perfusion and metabolism, using quantitative electroencephalography. Neuroimage 1: 208-219.
135. COOK, I. A. & A. F. LEUCHTER. 1996. Synaptic dysfunction in Alzheimer's disease: Clinical assessment using quantitative. EEG. Behav. Brain Res. 78: 15-23.
136. DE LA TORRE, J. C., H. M. KAWANAGA, D. W. ROWED et al. 1975. Dimethylsulfoxide in central nervous system trauma. Ann. N. Y. Acad. Sci 243: 362-389.
137. GILBOE, D. D., D. KINTNER, J. H. FITZPATRICK et al. 1991. Recovery of post ischemic brain metabolism and function following treatment with a free radical scavenger and platelet activating factor antagonists. J. Neurochem. 56: 311-319.
138. DUJOVNY, M., R. ROZARIO, N. KOSSODSVKY et al. 1983. Antiplatelet effect of dimethylsulfoxide, barbiturates and methyl prednisolone. Ann. N. Y. Acad. Sci. 411: 234-244.
139. DE LA TORRE, J. C., D. W. ROWED, H. M. KAWANAGA & S. MULLAN. 1973. Dimethylsulfoxide in the treatment of experimental brain compression. J. Neurosurg. 38: 345-354.
140. JACOB, S. W. & R. HERSCHLER. 1986. Pharmacology of DMSO. Cryobiology 23: 14-27.
141. DE LA TORRE, J. C. 1983. Role of dimethyl sulfoxide in prostaglandin-thromboxane and platelet systems after cerebral isechaemia. Ann. N. Y. Acad Sci. 411: 293-308.
142. MCLARNON, J. C., D. A. SAINT & D. M. QUASTEL. 1986. The actions of dimethyl sulfoxide on neuromuscular transmission. Mol. Pharmacol. 30: 631-638.
143. COHEN, S. G., S. B. CHISHTI, J. L. ELKIND et al. 1985. Effects of charge, volume, and surface on binding of inhibitor and substrate moieties to acetylcholinesterase. J. Med. Chem. 28: 1309-1313.
144. WATTS, J. A. & R. P. HOOGMOED. 1984. Dimethyl sulfoxide inhibition of acetylcholinesterase in the mammalian heart. Biochem. Pharmacol. 33: 365-369.
145. SAMS, W. M., N. V. CARROLL & P. C. CRANTZ. 1996. Effect of dimethylsulfoxide on isolated innervated skeletal, smooth and cardiac muscle. Proc. Soc. Exp. Biol. Med. 122: 103-107.
146. HILL, P. D., J. C. DE LA TORRE, S. M. THOMPSON et al. 1993. Ultrastructural studies of rat fasciculi gracilis unmyelinated fibers after contusion and DMSO treatment. Ann. N. Y. Acad Sci. 411: 200-217.
147. GELDRED, J. B., W. P. FIFE, D. E. BOWERS et al. 1983. Spinal cord transection in rats. The therapeutic effects of DMSO and hyperbaric oxygen. Ann. N. Y. Acad. Sci. 411: 218-233.
148. BROWN, F. D., L. JOHNS & S. MULLAN. 1983. Dimethyl sulfoxide therapy following penetrating brain injury. Spinal cord transection in rats. The therapeutic effects of DMSO and hyperbaric oxygen. Ann. N. Y. Acad. Sci. 411: 245-252.
149. WALLER, F. T., C. T. TNABE, D. PAXTON. 1983. Treatment of elevated intracranial pressure with dimethyl sulfoxide. Ann. N. Y. Acad. Sci. 411: 286-292.
150. HUCKER, H. B., J. K. MILLER, A. HOCHBERG et al. 1987. Studies on the absorption, excretion and metabolism of DMSO in man. J. Pharmacol. Exp. Ther. 155: 309-317.
151. TRICE, J. M. & R. S. PINALS. 1985. Dimethyl sulfoxide: A review of its use in the rheumatic disorders. Sem. Arthritis Rheum. 15: 45-60.
152. HERSCHLER, R & S. W. JACOB. 1980. The case of dimethyl sulfoxide. In Controversies in Therapeutics. L. Lasagna, Ed.: 519-529. W. B. Saunders. Philadephia, PA.
153. DE LA TORRE, J. C., C. T. ERNEST, R. WOLLMAN. 1981. Subacute toxicity of intravenous dimethyl sulfoxide in Rhesus monkeys. J. Toxicol. Environ. Health 7: 49-57.
154. JACOB, S. 1996. Pharma 21 communication. Oregon health Science Center, Portland, OR.
155. RAVID, M. D., I. KEDAR, E. SHOAR. 1977. Effect of a single dose of dimethyl sulfoxide on renal amyloidosis. Lancet i: 730-731.
156. HENDERSON, T. R., R. F. HENDERSON, ? LYNDAL & J. YORK. 1975. Effects of dimethyl sulfoxide on subunit proteins. Ann. N. Y. Acad. Sci. 243: 38-53.
157. ISOBE, T & E. OSSERMAN. 1976. Effects of dimethyl sulfoxide (DMSO) on Bence Jones proteins, amyloid fibrils and casein induced amyloidosis. In Amyloidosis. O. Weglius & A. Pasternack, Eds.: 247-257. Academic Press. New York.
158. KEDAR, I., M. GREENWALD & M. RAVID. 1977. Treatment of experimental murine amyloidosis with dimethyl sulfoxide. Eur. J. Clin. Invest. 7L: 149-150.
159. OSSERMAN, E. F., W. H. SHERMAN & R. A. KYLE. 1980. Further studies on therapy of amyloidosis with dimethyl sulfoxide (DMSO). In Amyloid and Amyloidosis. G. G. Glenner, P. P. Costa & F. Fretas, Eds.: 563-569. Excerpta Medica. Amsterdam.
160. HANAI, N., T. ISHIHARA, F. MUCHINO et al. 1979. Effect of dimethyl sulfoxide and colchicine on the resorption of experimental amyloid. Virchows Arch. (Pathol. Anat) 384: 42-45.
161. GREENWALD, M., I. KEDAR & E. SOHAR. 1980. The effect of colchicine and DMSO on the genetic amyloidosis of the White Pekin Duck. In Amyloid and Amyloidosis. G. Glenner, P. Costa & F. Freitas, Eds.: 585-586. Excerpta Medica. Amsterdam.
162. EISENBUD, L. E., C. P. LERNER, & C. K. CHAI. 1980. The effect of DMSO upon spontaneous amyloidosis in mice. Proc. Soc. Exp. Biol. Med. 168: 172-174.
163. LOFFLER, H. J., H. BRASS, W. THOENES & A. P. LINKE. 1983. Familiares mittelmeer fieber mit amyloidose. Dtsch. Med. Wschr. 108: 210-215.
164. MADHAVEN, M. & K. R. RAO. 1986. DMSO-induced regression of experimental amyloidosis in mice. A preliminary study. Ind. J. Pathol. Microbiol. 29: 109-114.
165. KITO, L. S., E. ITOGA & M. HIRONAKA et al. 1983. Studies on biological actions of dimethyl sulfoxide in familial amyloidosis. Ann. N. Y. Acad. Sci. 411: 52-65.
166. SPYRIDAKIS, L., S. BROWN, J. BARSANTI et al. 1986. Amyloidosis in dog: Treatment with dimethyl sulfoxide. J. Am. V. A. 189: 690-691.
167. SCHEINBEG, M. D., J. PERNAMBUCO & M. D. BENSON. 1984. DMSO and colchicine therapy in amyloid disease. Ann. Rheum. Dis. 43: 421-423.
168. WANG, W. J., L. CHANG-SHI & C. K. WONG. 1986. Response of systemic amyloidosis to dimethyl sulfoxide. J. Am. Acad. Derm. 15: 402-405.
169. ALYABYEVA, A. P. & Y. V. MURAVYEV. 1983. Control trials of dimethyl sulfoxide in rheumatoid and collagen disease. Ann. N. Y. Acad. Sci. 411: 309-315.
170. YOSHIMITSU, K., N. KOGA, Y. KITAMURA et al. 1984. Favorable effect of dimethyl sulfoxide on secondary amyloidosis in juvenile rheumatoid arthritis. Pediat. Pharm. 4: 177-181.
171. BREATHNSACH, S. M. 1985. The cutaneous amyloidosis. Arch. Derm. 121: 470-475.
172. OZAKI, M. 1984. Familial lichen amyloidosis. Int. J. Dermatol. 23: 190-193.
173. MONTFRECOLA, G., R. IANDODLI, G. BRUNO & D. MARTELLOTTA. 1985. Lichen amyloidosis: A new therapeutic approach. Arch. Derm. Venereol. (Stockh.) 65: 453-455.
174. FLAIM, S. F. 1997. Perflubron-based emulsion: Efficacy as a temporary oxygen carrier. In Blood Substitutes: New Frontiers. R. M. Wilson, K. D. Vandedgriff & M. Intaglietta, Eds. Brikhauser. Boston, MA. In press. [Note: For further information contact: Alliance Pharmaceutical Corp. 3040 Science Park, San Diego, CA 92121.]
175. NAGATA, K., R. J. BUCHAN et al. 1997. Misery perfusion with preserved vascular reactivity in Alzheimer's disease. Ann. N. Y. Acad. Sci.
176. FELICETTI, J. V. & J. R. SOWERS. 1986. The thyroid and aging. In The Thyroid Gland. L. Van Middlesworth, Ed.: 131-147. Year Book Medical Publisher, Chicago, IL.
177. GRIFFIN, J. E. 19XX. Review: Hypothyroidism in the elderly. Am. J. Med. Sci. 299: 334-345.
178. PIERPAOLI, W., W. REGELSON & C. COLEMAN. 1995. The Melatonin Miracle. Simon & Schuster. New York.
179. REGELSON, W & C. COLEMAN. 1996. Melatonin. In The Super Hormone Promise: 221-296. Simon and Schuster. New York.
180. REITER, R. 1995. Melatonin. Bantam Books. New York.
181. PIERPAOLI, W. & W. REGELSON. 1994. Pineal control of aging. Effect of melatonin and pineal grafting on aging mice. Proc. Natl. Acad. Sci. USA 91: 787-791.
182. ACUNA-CASTROVIEJO, D., G. ESCAMES, M. MACIAS et al. 1995. Cell protective role of melatonin in the brain. J. Pineal Res. 190: 57-63.
183. REITER, R. J., D. X. TAN, B. POEGGELER et al. 1994. Melatonin as a free radical scavenger: Implication for aging and age-related diseases. Ann. N. Y. Acad. Sci. 719: 1-12.
184. REGELSON, W. & C. COLEMAN. 1996. Two superhormones capturing the spotlight. DHEA (chapt. I): 39-101; Pregnenalone (chapt. II): 102-113. In The Superhormone Promise. Simon and Schuster. New York.
185. KALIMI, M. & W. REGELSON, Eds. 1990. The Biologic Role of Dehydroepiandrosterone (DHEA). de Gruyter. Berlin.
186. BELLINO, F. L., R. A. DAYNES, J. HORNSBY et al. Eds: 1995. Dehydroepiandrosterone (DHEA) and Aging. Ann. N. Y. Acad. Sci. 774: 1-350.
187. WOLKOWITZ, O. M., V. I. REUS, E. ROBERTS et al. 1995. Antidepressant and cognition enhancing effects of DHEA in major depression. Ann N. Y. Acad. Sci. 774: 337-339.
188. DIAMOND, D. M., B. J. BRANACH, M. FLESHNER & G. M. ROSE. 1995. Effect of dehydroepiandrosterone sulfate and stress on hippocampal electrophysiological plasticity. Ann. N. Y. Acad. Sci. 774: 394-407.
189. DANNENBERG, H. D., R. HARING, E. HELDMAN et al. 1995. Dehydroepiandrosterone augments M1-muscarinic receptor-stimulated amyloid precursor protein secretion in desensitized PC12 μ1 cells. Ann. N. Y. Acad. Sci. 774: 300-303.
190. BELLINGER, F. P., S. G. MADAMBA, I. L. CAMPBELL & G. R. SIGGINS. 1995. Reduced long term potentiation in the dentate gyrus of transgenic mice and cerebral expression of interleukin 6. Neurosci. Lett. 198: 95-98.
191. JAKUBOWICZ, D., N. BEER, R. RENGIFO. 1995. Effect of dehydroepiandrosterone on cyclic-guanosine monophosphate in men of advancing age. Ann. N. Y. Acad. Sci. 774: 312-315.
192. BEHAN, F. L., S. C. HEINRICHS, J. C. TRONCOSO et al. 1995. Displacement of corticotropin releasing factor from its binding protein as a possible treatment for Alzheimer's disease. Nature 378: 284-287.
193. SCHNEIDER, L. S. & M. FARLOW. 1997. Combined tacrine and estrogen replacement therapy in patients with Alzheimer's disease. Ann. N. Y. Acad. Sci. This volume.
194. CHERKIN, A., FLOOD, J. F. 1983. Remarkable potentiation among memory enhancing cholinergic drugs in mice. In Intervention in the Aging Process, Part A. W. Regelson & M. Sinex, Eds.: 225-245. Alan R. Liss. New York.
195. FLOOD, J. F., W. D. LANDRY & M. E. JARVIK. 1981. Cholinergic
196. SCREMIN, O. U., A. M. E. SCREMIN, D. HEUSER et al. Prolonged effects of cholinesterase inhibition with eptastigmine on the cerebral blood flow, metabolism rates of normal rats. J. Cereb. Bld. Flow. Metab. 13: 702-711.
197. BASSANT, M. H., F. JAZAT-POINDESSOUS & Y. LAMOUR. 1996. Effect of metrifonate, a cholinesterase inhibitor on local cerebral gluocse utilization in young and aged rats. J. Cereb. Blood Flow Metab. 16: 1014-1025.
198. FERRIS, E. H., G. SATHANANTHAN, S. GEDRSHON & C. CLARK. 1977. Senile dementia: Treatment with Deanol. J. Am. Geriatric Soc. 25: 241-244.
199. SCHUBERT, P. et al. 1997. Support of homeostatic glial reactions: A novel therapeutic action by propentofylline. Ann. N. Y. Acad. Sci.
200. CHODOBSKI, A., J. SZYMYDYNGER-CHODODBSKA, H. EPSTEIN & C. E. JOHNSON. 1995. The role of angiotensin II in the regulation of blood flow to choroid plexuses and cerebrospinal fluid formation in the rat. J. Cereb. Blood Flow Metab. 15: 143-151.
201. LOPEZ, B. L., T. A. CHRISTOPHER, J. L. YUE et al. 1995. Carvedilol, a new beta adrenoreceptor blocker antihypertensive drug, protects against free radical induced endothe lial dysfunction. Pharmacology 51: 165-173.
202. MIWA, S., Y. WATANABE, K. KOSHIMURA & T. MASAKI. 1992. A novel function of tetrahydrobiopterin. Nippon Yakurigaku Zasshi 100: 367-381.
203. LOVENBERG, W., R. A. LEVINE, M. A. AIKEN et al. 1983. Regulation of biogenic amine synthesis by the hydroxylase cofactor and its relation to aging and Parkinsonism. In Intervention in the Aging Process. W. Regelson & M. Sinex, Eds.: 215-224. Alan R. Liss. New York.
204. BECKMAN, J. S., J. CHEN, J. ISCHIIROPOULOS et al. 1993. Nitric oxide as a mediator of cerebral blood flow, synaptic plasticity and superoxide-mediated brain injury. In Oxygen Radicals in Tissue Damage. M. Tarr & F. Samson, Eds.: 174-193. Birkhouser. Boston, MA.
205. LOPES-CARDOZO, R. H., A. J. DE BEAUFORT, B. J. GESINK et al. 1996. Inhalation of nitric oxide: Effect on cerebral hemodynamics and activity, and anti-oxidant status in the newborn lamb. Biol. Neonat. 69: 284-292.
206. DURHEIM, M. A., W. R. TRACEY, J. S. POLLOCK & P. GRAMMAS. 1994. Nitric oxide synthase activity is elevated in brain microvessels in Alzheimer's disease. Biochem. Biophys. Res. Commun. 205: 659-665.
207. GOODWIN, J. L., E. UEMORA & J. E. CUNNICK. 1995. Microglial release of nitric oxide by the synergistic action of beta-amyloid and IFN-gamma. Brain Res. 692: 207-214.
208. ROSSI, F. & E. BIANCHINI. 1996. Synergistic induction of nitric oxide by beta-amyloid and cytokines in astrocytes. Biochim. Biophys. Res. Commun. 225: 474-478.
209. KUIPER, M. A., J. J. VISSER, P. L. BERGMANS et al. 1994. Decreased cerebrospinal fluid nitrate levels in Parkinson's disease, Alzheimer's disease and multiple system atrophy in patients. J. Neural Sci. 121: 46-49.
210. IWAMA, T., HASHIMOTO & Y. YONEKAWA. 1996. The relevance of hemodynamic factors to perioperative ischemic complications in moya moya disease. Neurosurgery 38: 1120-1125.
211. 2 reaction in open heart surgery. Masui 45: 287-292.
212. 2 dependence of retinal arterial and capillary blood velocity. Acta Opthalmol. Scand. 73: 421-424.
213. FATIGANATE, L., F. CARTEI, F. DUCCI et al. 1994. Carbogen breathing in patients with glioblastoma multiforme submitted to radiotherapy Acta Oncol. 33: 807-811.
214. 2-dependent cerebrovascular reactivity. Acta Neurochir. Wien 136: 186-188.